Welcome to the new Gustave Roussy website
A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.
Applications open for the 2026 Gustave Roussy Prize
Inaugurated this year, the Gustave Roussy Prize returns in 2026 to honor a researcher whose scientific discoveries have had a major impact on cancer care. Endowed with €200,000, this prestigious international award recognizes groundbreaking contributions to oncology.
Published on
Changed on
Inaugurated this year, the Gustave Roussy Prize returns in 2026 to honor a researcher whose scientific discoveries have had a major impact on cancer care. Endowed with €200,000, this prestigious international award recognizes groundbreaking contributions to oncology.
Applications are now open and will be accepted until September 4, 2025. The winner will be announced on World Cancer Day, 4 February 2026.
A pioneer in oncology, Professor Gustave Roussy revolutionized cancer medicine by establishing dedicated cancer consultation in 1921. Established to commemorate the 150th anniversary of Professor Gustave Roussy birth and the 100th anniversary of the Institute that bears his name, the Gustave Roussy Prize recognizes a leading researcher in oncology, whose scientific discoveries in diagnosis, treatment or prevention, have led to significant improvements in patient care or understanding of the disease.
This prize celebrates scientific excellence and patient-centered innovation in line with Gustave Roussy's mission: to cure people more effectively.
The €200,000 prize is one of the most generous global awards dedicated to fight against cancer.
Application deadline: 4 September 2025, 4pm (CEST)
Researchers of all nationalities are invited to submit an application by September 4, 2025, 4pm (CEST), via the online form: application deadline
Applications will be reviewed by an independent jury of international experts, based on criteria of scientific excellence and clinical impact, without distinction of discipline or institutional affiliation.
The Gustave Roussy Prize is awarded annually by Fondation Gustave Roussy , with the generous support of Pierre Fabre Laboratories, founding sponsor.
More about :
► The inaugural edition of the Gustave Roussy Prize awarded to Professor Charles Swanton
Last news
-
Breast Cancer: Gustave Roussy Ranked No. 1 in France for Breast Surgery and Breast Reconstruction
On the occasion of Breast Cancer Awareness Month, the 2025 data from Visuchir, the national surgical activity monitoring tool of the French Health Insurance system, places Gustave Roussy in first position for both breast surgery and breast reconstruction. Beyond this ranking, these figures highlight that reconstruction is now an integral part of breast cancer treatment. It is considered at every stage of care: from tumor removal surgery, whether lumpectomy or mastectomy, through to the post-cancer period, helping to restore the body and support women in regaining their physical integrity and quality of life.
-
Newsweek Ranking: Gustave Roussy Named Europe’s Leading Cancer Centre and Third Best Worldwide
The 2027 edition of Newsweek’s World's Best Specialized Hospitals ranking once again recognises Gustave Roussy as the leading cancer centre in France and Europe, and the third best worldwide. This distinction highlights the excellence of the Institute’s care and research, as well as the daily commitment of all its professionals.
-
Living with and beyond cancer: the promises and challenges of digital health
In a Viewpoint article published in The Lancet Digital Health, Drs Ines Vaz-Luis and Maria Alice Franzoi, together with Emmanuel Mussault, a patient partner at the PRISM University Hospital Institute, examine the role that digital tools can play in supporting people living with and beyond cancer. Their central message is that these technologies can support more personalised and accessible care, but their value depends primarily on how they are integrated into care pathways, the human support provided, their ability to address individual needs and their evaluation in real-world settings.
-
Gustave Roussy and The Lancet launch an international lecture series on innovations transforming cancer care
The inaugural lecture in the “Lecture Series on Cancer Breakthroughs” will take place on Friday 18 September at 5:00 pm. It will be delivered by Professor Timothy R. Rebbeck, a leading cancer prevention specialist at Harvard University and the Dana-Farber Cancer Institute.
